_id
690db0d9ccc777a4e85d0baf
Ticker
ARNI
Name
Arno Therapeutics
Exchange
OTCGREY
Address
200 Route 31 North, Flemington, NJ, United States, 08822
Country
USA
Sector
Healthcare
Industry
Biotechnology
Currency
USD
Website
https://www.arnothera.com
Description
Arno Therapeutics, Inc., a biopharmaceutical company, develops products for the treatment of cancer and other life threatening diseases. The company's product development pipeline includes Onapristone, a type 1 anti-progestin hormone blocker that is in Phase I/II clinical study for the treatment of breast, endometrial, and others solid tumors in post-menopausal women; and advanced castration-resistant prostate cancer in men. Its product development pipeline also consists of AR-12, an orally available cancer treatment, which has completed Phase I clinical study for the treatment of solid tumors and hematological malignancies, as well as in Pre-clinical studies for the treatment of various anti-microbial targets. In addition, the company's product development pipeline comprises AR-42, a novel orally available cancer therapy that is in Phase I investigator-initiated clinical study for the treatment of hematological malignancies and solid tumors. The company has license agreements with Invivis Pharmaceuticals, Inc.; the Regents of the University of Minnesota; and the Ohio State University Innovation Foundation, as well as a co-development agreement with Leica Biosystems Newcastle Ltd. Arno Therapeutics, Inc. was founded in 2005 and is based in Flemington, New Jersey.
Last Close
0.0001
Volume
800
Current Price
0.0002
Change
0
Last Updated
2026-01-20T15:39:48.480Z
Image
data:image/webp;base64,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
Ipo Date
-
Market Cap
9869
Next Dividend Date
-
Dividend Frequency
-
Dividend Rate
-
Dividend Yield
0
Sentiment
-
Sentiment Sources
0
Current Quarter
2016-09-30
Revenue
0
Cost Of Revenue
0
Gross Profit
0
Operating Expenses
2231267
Operating Income
-2231267
Interest Expense
214
Pretax Income
-3849015
Net Income
-3849015
Eps
-
Dividends Per Share
-
Shares Outstanding
49349749
Income Tax Expense
0
EBITDA
-
Operating Margin
-
Total Other Income Expense Net
-1617748
Cash
2124079
Short Term Investments
-
Receivables
-
Inventories
-
Total Current Assets
2327433
Property Plant Equipment
17741
Total Assets
2355629
Payables
1065320
Short Term Debt
5088
Long Term Debt
1000
Total Liabilities
8069873
Equity
-5714244
Bs_currency_symbol
USD
Depreciation
1801
Change In Working Capital
-
Cash From Operations
-1140133
Capital Expenditures
0
Cash From Investing
-
Cash From Financing
2326857
Net Change In Cash
1186724
Cf_currency_symbol
USD
PE
-
PB
-
ROE
67.35825421525577
ROA
-163.39648560957605
FCF
-1140133
Fcf Percent
-
Piotroski FScore
1
Health Score
49
Deep Value Investing Score
2
Defensive Investing Score
7
Dividend Investing Score
1.5
Economic Moat Investing Score
5.3
Garp Investing Score
2
Growth Investing Score
2
Momentum Investing Score
3.5
Net Net Investing Score
2
Quality Investing Score
2.5
Value Investing Score
2.5
Quarters > 0 > quarter
2016-09-30
Quarters > 0 > income Statement > revenue
0
Quarters > 0 > income Statement > cost Of Revenue
0
Quarters > 0 > income Statement > gross Profit
0
Quarters > 0 > income Statement > operating Expenses
2231267
Quarters > 0 > income Statement > operating Income
-2231267
Quarters > 0 > income Statement > interest Expense
214
Quarters > 0 > income Statement > pretax Income
-3849015
Quarters > 0 > income Statement > net Income
-3849015
Quarters > 0 > income Statement > eps
-
Quarters > 0 > income Statement > dividends Per Share
-
Quarters > 0 > income Statement > shares Outstanding
-
Quarters > 0 > income Statement > income Tax Expense
0
Quarters > 0 > income Statement > EBITDA
-
Quarters > 0 > income Statement > operating Margin
-
Quarters > 0 > income Statement > total Other Income Expense Net
-1617748
Quarters > 0 > income Statement > currency_symbol
USD
Quarters > 0 > balance Sheet > cash
2124079
Quarters > 0 > balance Sheet > short Term Investments
-
Quarters > 0 > balance Sheet > receivables
-
Quarters > 0 > balance Sheet > inventories
-
Quarters > 0 > balance Sheet > total Current Assets
2327433
Quarters > 0 > balance Sheet > property Plant Equipment
17741
Quarters > 0 > balance Sheet > total Assets
2355629
Quarters > 0 > balance Sheet > payables
1065320
Quarters > 0 > balance Sheet > short Term Debt
5088
Quarters > 0 > balance Sheet > long Term Debt
1000
Quarters > 0 > balance Sheet > total Liabilities
8069873
Quarters > 0 > balance Sheet > equity
-5714244
Quarters > 0 > balance Sheet > currency_symbol
USD
Quarters > 0 > cash Flow > net Income
-3849015
Quarters > 0 > cash Flow > depreciation
1801
Quarters > 0 > cash Flow > change In Working Capital
-
Quarters > 0 > cash Flow > cash From Operations
-1140133
Quarters > 0 > cash Flow > capital Expenditures
0
Quarters > 0 > cash Flow > cash From Investing
-
Quarters > 0 > cash Flow > cash From Financing
2326857
Quarters > 0 > cash Flow > net Change In Cash
1186724
Quarters > 0 > cash Flow > currency_symbol
USD
Quarters > 0 > ratios > PE
-
Quarters > 0 > ratios > PB
-
Quarters > 0 > ratios > ROE
67.35825421525577
Quarters > 0 > ratios > ROA
-163.39648560957605
Quarters > 0 > ratios > FCF
-1140133
Quarters > 0 > ratios > Piotroski FScore
1
Quarters > 0 > ratios > fcf Percent
-
Quarters > 0 > health Score
49
Quarters > 1 > quarter
2016-06-30
Quarters > 1 > income Statement > revenue
0
Quarters > 1 > income Statement > cost Of Revenue
0
Quarters > 1 > income Statement > gross Profit
0
Quarters > 1 > income Statement > operating Expenses
3310534
Quarters > 1 > income Statement > operating Income
-3310534
Quarters > 1 > income Statement > interest Expense
250
Quarters > 1 > income Statement > pretax Income
-2142488
Quarters > 1 > income Statement > net Income
-2142488
Quarters > 1 > income Statement > eps
-
Quarters > 1 > income Statement > dividends Per Share
-
Quarters > 1 > income Statement > shares Outstanding
-
Quarters > 1 > income Statement > income Tax Expense
0
Quarters > 1 > income Statement > EBITDA
-
Quarters > 1 > income Statement > operating Margin
-
Quarters > 1 > income Statement > total Other Income Expense Net
1168046
Quarters > 1 > income Statement > currency_symbol
USD
Quarters > 1 > balance Sheet > cash
937355
Quarters > 1 > balance Sheet > short Term Investments
-
Quarters > 1 > balance Sheet > receivables
-
Quarters > 1 > balance Sheet > inventories
-
Quarters > 1 > balance Sheet > total Current Assets
1068806
Quarters > 1 > balance Sheet > property Plant Equipment
19542
Quarters > 1 > balance Sheet > total Assets
1098803
Quarters > 1 > balance Sheet > payables
709401
Quarters > 1 > balance Sheet > short Term Debt
6068
Quarters > 1 > balance Sheet > long Term Debt
2000
Quarters > 1 > balance Sheet > total Liabilities
6317316
Quarters > 1 > balance Sheet > equity
-5218513
Quarters > 1 > balance Sheet > currency_symbol
USD
Quarters > 1 > cash Flow > net Income
-2142488
Quarters > 1 > cash Flow > depreciation
1780
Quarters > 1 > cash Flow > change In Working Capital
-
Quarters > 1 > cash Flow > cash From Operations
-1679890
Quarters > 1 > cash Flow > capital Expenditures
0
Quarters > 1 > cash Flow > cash From Investing
-
Quarters > 1 > cash Flow > cash From Financing
-66695
Quarters > 1 > cash Flow > net Change In Cash
-1746585
Quarters > 1 > cash Flow > currency_symbol
USD
Quarters > 1 > ratios > PE
-
Quarters > 1 > ratios > PB
-
Quarters > 1 > ratios > ROE
41.05552673721422
Quarters > 1 > ratios > ROA
-194.9838142050941
Quarters > 1 > ratios > FCF
-1679890
Quarters > 1 > ratios > Piotroski FScore
1
Quarters > 1 > ratios > fcf Percent
-
Quarters > 1 > health Score
49
Quarters > 2 > quarter
2016-03-31
Quarters > 2 > income Statement > revenue
0
Quarters > 2 > income Statement > cost Of Revenue
0
Quarters > 2 > income Statement > gross Profit
0
Quarters > 2 > income Statement > operating Expenses
2825286
Quarters > 2 > income Statement > operating Income
-2825286
Quarters > 2 > income Statement > interest Expense
14518
Quarters > 2 > income Statement > pretax Income
-3708947
Quarters > 2 > income Statement > net Income
-3708947
Quarters > 2 > income Statement > eps
-
Quarters > 2 > income Statement > dividends Per Share
-
Quarters > 2 > income Statement > shares Outstanding
-
Quarters > 2 > income Statement > income Tax Expense
0
Quarters > 2 > income Statement > EBITDA
-
Quarters > 2 > income Statement > operating Margin
-
Quarters > 2 > income Statement > total Other Income Expense Net
-883661
Quarters > 2 > income Statement > currency_symbol
USD
Quarters > 2 > balance Sheet > cash
2683940
Quarters > 2 > balance Sheet > short Term Investments
-
Quarters > 2 > balance Sheet > receivables
-
Quarters > 2 > balance Sheet > inventories
-
Quarters > 2 > balance Sheet > total Current Assets
2892584
Quarters > 2 > balance Sheet > property Plant Equipment
21322
Quarters > 2 > balance Sheet > total Assets
2924361
Quarters > 2 > balance Sheet > payables
787881
Quarters > 2 > balance Sheet > short Term Debt
7012
Quarters > 2 > balance Sheet > long Term Debt
3000
Quarters > 2 > balance Sheet > total Liabilities
6947567
Quarters > 2 > balance Sheet > equity
-4023206
Quarters > 2 > balance Sheet > currency_symbol
USD
Quarters > 2 > cash Flow > net Income
-3708947
Quarters > 2 > cash Flow > depreciation
1781
Quarters > 2 > cash Flow > change In Working Capital
-
Quarters > 2 > cash Flow > cash From Operations
-2654887
Quarters > 2 > cash Flow > capital Expenditures
0
Quarters > 2 > cash Flow > cash From Investing
-
Quarters > 2 > cash Flow > cash From Financing
5271839
Quarters > 2 > cash Flow > net Change In Cash
2616952
Quarters > 2 > cash Flow > currency_symbol
USD
Quarters > 2 > ratios > PE
-
Quarters > 2 > ratios > PB
-
Quarters > 2 > ratios > ROE
92.18884143640669
Quarters > 2 > ratios > ROA
-126.82931416470129
Quarters > 2 > ratios > FCF
-2654887
Quarters > 2 > ratios > Piotroski FScore
1
Quarters > 2 > ratios > fcf Percent
-
Quarters > 2 > health Score
49
Quarters > 3 > quarter
2015-12-31
Quarters > 3 > income Statement > revenue
0
Quarters > 3 > income Statement > cost Of Revenue
0
Quarters > 3 > income Statement > gross Profit
0
Quarters > 3 > income Statement > operating Expenses
2695538
Quarters > 3 > income Statement > operating Income
-2695538
Quarters > 3 > income Statement > interest Expense
27264
Quarters > 3 > income Statement > pretax Income
-3994990
Quarters > 3 > income Statement > net Income
-3994990
Quarters > 3 > income Statement > eps
-
Quarters > 3 > income Statement > dividends Per Share
-
Quarters > 3 > income Statement > shares Outstanding
-
Quarters > 3 > income Statement > income Tax Expense
0
Quarters > 3 > income Statement > EBITDA
-
Quarters > 3 > income Statement > operating Margin
-
Quarters > 3 > income Statement > total Other Income Expense Net
-1299452
Quarters > 3 > income Statement > currency_symbol
USD
Quarters > 3 > balance Sheet > cash
66988
Quarters > 3 > balance Sheet > short Term Investments
-
Quarters > 3 > balance Sheet > receivables
-
Quarters > 3 > balance Sheet > inventories
-
Quarters > 3 > balance Sheet > total Current Assets
327682
Quarters > 3 > balance Sheet > property Plant Equipment
23103
Quarters > 3 > balance Sheet > total Assets
361240
Quarters > 3 > balance Sheet > payables
1010215
Quarters > 3 > balance Sheet > short Term Debt
2097832
Quarters > 3 > balance Sheet > long Term Debt
3000
Quarters > 3 > balance Sheet > total Liabilities
8985334
Quarters > 3 > balance Sheet > equity
-8624094
Quarters > 3 > balance Sheet > currency_symbol
USD
Quarters > 3 > cash Flow > net Income
-3994990
Quarters > 3 > cash Flow > depreciation
1805
Quarters > 3 > cash Flow > change In Working Capital
-
Quarters > 3 > cash Flow > cash From Operations
-2142879
Quarters > 3 > cash Flow > capital Expenditures
0
Quarters > 3 > cash Flow > cash From Investing
-
Quarters > 3 > cash Flow > cash From Financing
2086595
Quarters > 3 > cash Flow > net Change In Cash
-56284
Quarters > 3 > cash Flow > currency_symbol
USD
Quarters > 3 > ratios > PE
-
Quarters > 3 > ratios > PB
-
Quarters > 3 > ratios > ROE
46.32359062876634
Quarters > 3 > ratios > ROA
-1105.9101982061786
Quarters > 3 > ratios > FCF
-2142879
Quarters > 3 > ratios > Piotroski FScore
1
Quarters > 3 > ratios > fcf Percent
-
Quarters > 3 > health Score
49
Annuals > 0 > quarter
2015-12-31
Annuals > 0 > income Statement > revenue
0
Annuals > 0 > income Statement > cost Of Revenue
0
Annuals > 0 > income Statement > gross Profit
0
Annuals > 0 > income Statement > operating Expenses
13411811
Annuals > 0 > income Statement > operating Income
-13411811
Annuals > 0 > income Statement > interest Expense
0
Annuals > 0 > income Statement > pretax Income
-11507963
Annuals > 0 > income Statement > net Income
-11507963
Annuals > 0 > income Statement > eps
-
Annuals > 0 > income Statement > dividends Per Share
-
Annuals > 0 > income Statement > shares Outstanding
-
Annuals > 0 > income Statement > income Tax Expense
0
Annuals > 0 > income Statement > EBITDA
-
Annuals > 0 > income Statement > operating Margin
-
Annuals > 0 > income Statement > total Other Income Expense Net
1903848
Annuals > 0 > income Statement > currency_symbol
USD
Annuals > 0 > balance Sheet > cash
66988
Annuals > 0 > balance Sheet > short Term Investments
-
Annuals > 0 > balance Sheet > receivables
-
Annuals > 0 > balance Sheet > inventories
-
Annuals > 0 > balance Sheet > total Current Assets
327682
Annuals > 0 > balance Sheet > property Plant Equipment
23103
Annuals > 0 > balance Sheet > total Assets
361240
Annuals > 0 > balance Sheet > payables
1010215
Annuals > 0 > balance Sheet > short Term Debt
2097832
Annuals > 0 > balance Sheet > long Term Debt
3000
Annuals > 0 > balance Sheet > total Liabilities
8985334
Annuals > 0 > balance Sheet > equity
-8624094
Annuals > 0 > balance Sheet > currency_symbol
USD
Annuals > 0 > cash Flow > net Income
-11507963
Annuals > 0 > cash Flow > depreciation
7627
Annuals > 0 > cash Flow > change In Working Capital
-
Annuals > 0 > cash Flow > cash From Operations
-9965598
Annuals > 0 > cash Flow > capital Expenditures
0
Annuals > 0 > cash Flow > cash From Investing
-
Annuals > 0 > cash Flow > cash From Financing
2084150
Annuals > 0 > cash Flow > net Change In Cash
-7881448
Annuals > 0 > cash Flow > currency_symbol
USD
Annuals > 0 > ratios > PE
-
Annuals > 0 > ratios > PB
-
Annuals > 0 > ratios > ROE
133.43967493860805
Annuals > 0 > ratios > ROA
-3185.6834791274496
Annuals > 0 > ratios > FCF
-9965598
Annuals > 0 > ratios > Piotroski FScore
1
Annuals > 0 > ratios > fcf Percent
-
Annuals > 0 > health Score
41
Annuals > 1 > quarter
2014-12-31
Annuals > 1 > income Statement > revenue
0
Annuals > 1 > income Statement > cost Of Revenue
0
Annuals > 1 > income Statement > gross Profit
0
Annuals > 1 > income Statement > operating Expenses
21093326
Annuals > 1 > income Statement > operating Income
-21093326
Annuals > 1 > income Statement > interest Expense
0
Annuals > 1 > income Statement > pretax Income
7770767
Annuals > 1 > income Statement > net Income
7770767
Annuals > 1 > income Statement > eps
-
Annuals > 1 > income Statement > dividends Per Share
-
Annuals > 1 > income Statement > shares Outstanding
-
Annuals > 1 > income Statement > income Tax Expense
0
Annuals > 1 > income Statement > EBITDA
-
Annuals > 1 > income Statement > operating Margin
-
Annuals > 1 > income Statement > total Other Income Expense Net
28864093
Annuals > 1 > income Statement > currency_symbol
USD
Annuals > 1 > balance Sheet > cash
7948436
Annuals > 1 > balance Sheet > short Term Investments
-
Annuals > 1 > balance Sheet > receivables
-
Annuals > 1 > balance Sheet > inventories
-
Annuals > 1 > balance Sheet > total Current Assets
8206482
Annuals > 1 > balance Sheet > property Plant Equipment
30730
Annuals > 1 > balance Sheet > total Assets
8247667
Annuals > 1 > balance Sheet > payables
742448
Annuals > 1 > balance Sheet > short Term Debt
11245
Annuals > 1 > balance Sheet > long Term Debt
8000
Annuals > 1 > balance Sheet > total Liabilities
5288173
Annuals > 1 > balance Sheet > equity
-588891
Annuals > 1 > balance Sheet > currency_symbol
USD
Annuals > 1 > cash Flow > net Income
7770767
Annuals > 1 > cash Flow > depreciation
12586
Annuals > 1 > cash Flow > change In Working Capital
-
Annuals > 1 > cash Flow > cash From Operations
-18805416
Annuals > 1 > cash Flow > capital Expenditures
20096
Annuals > 1 > cash Flow > cash From Investing
-20096
Annuals > 1 > cash Flow > cash From Financing
-255
Annuals > 1 > cash Flow > net Change In Cash
-18825767
Annuals > 1 > cash Flow > currency_symbol
USD
Annuals > 1 > ratios > PE
-
Annuals > 1 > ratios > PB
-
Annuals > 1 > ratios > ROE
-1319.5594770509313
Annuals > 1 > ratios > ROA
94.21775879166799
Annuals > 1 > ratios > FCF
-18825512
Annuals > 1 > ratios > Piotroski FScore
1
Annuals > 1 > ratios > fcf Percent
-
Annuals > 1 > health Score
36
Annuals > 2 > quarter
2013-12-31
Annuals > 2 > income Statement > revenue
0
Annuals > 2 > income Statement > cost Of Revenue
0
Annuals > 2 > income Statement > gross Profit
0
Annuals > 2 > income Statement > operating Expenses
16940549
Annuals > 2 > income Statement > operating Income
-16940549
Annuals > 2 > income Statement > interest Expense
0
Annuals > 2 > income Statement > pretax Income
-39656975
Annuals > 2 > income Statement > net Income
-39656975
Annuals > 2 > income Statement > eps
-
Annuals > 2 > income Statement > dividends Per Share
-
Annuals > 2 > income Statement > shares Outstanding
-
Annuals > 2 > income Statement > income Tax Expense
0
Annuals > 2 > income Statement > EBITDA
-
Annuals > 2 > income Statement > operating Margin
-
Annuals > 2 > income Statement > total Other Income Expense Net
-22716426
Annuals > 2 > income Statement > currency_symbol
USD
Annuals > 2 > balance Sheet > cash
26774203
Annuals > 2 > balance Sheet > short Term Investments
-
Annuals > 2 > balance Sheet > receivables
-
Annuals > 2 > balance Sheet > inventories
-
Annuals > 2 > balance Sheet > total Current Assets
26860469
Annuals > 2 > balance Sheet > property Plant Equipment
11720
Annuals > 2 > balance Sheet > total Assets
26882644
Annuals > 2 > balance Sheet > payables
2941998
Annuals > 2 > balance Sheet > short Term Debt
-
Annuals > 2 > balance Sheet > long Term Debt
35864881
Annuals > 2 > balance Sheet > total Liabilities
39403518
Annuals > 2 > balance Sheet > equity
-12883326
Annuals > 2 > balance Sheet > currency_symbol
USD
Annuals > 2 > cash Flow > net Income
-39656975
Annuals > 2 > cash Flow > depreciation
13117
Annuals > 2 > cash Flow > change In Working Capital
-
Annuals > 2 > cash Flow > cash From Operations
-14242576
Annuals > 2 > cash Flow > capital Expenditures
20096
Annuals > 2 > cash Flow > cash From Investing
-20096
Annuals > 2 > cash Flow > cash From Financing
30073342
Annuals > 2 > cash Flow > net Change In Cash
15830766
Annuals > 2 > cash Flow > currency_symbol
USD
Annuals > 2 > ratios > PE
-
Annuals > 2 > ratios > PB
-
Annuals > 2 > ratios > ROE
307.8162812925793
Annuals > 2 > ratios > ROA
-147.51887872338747
Annuals > 2 > ratios > FCF
-14262672
Annuals > 2 > ratios > Piotroski FScore
0
Annuals > 2 > ratios > fcf Percent
-
Annuals > 2 > health Score
40
Annuals > 3 > quarter
2012-12-31
Annuals > 3 > income Statement > revenue
0
Annuals > 3 > income Statement > cost Of Revenue
0
Annuals > 3 > income Statement > gross Profit
0
Annuals > 3 > income Statement > operating Expenses
10835801
Annuals > 3 > income Statement > operating Income
-10835801
Annuals > 3 > income Statement > interest Expense
0
Annuals > 3 > income Statement > pretax Income
-14387782
Annuals > 3 > income Statement > net Income
-14387782
Annuals > 3 > income Statement > eps
-
Annuals > 3 > income Statement > dividends Per Share
-
Annuals > 3 > income Statement > shares Outstanding
-
Annuals > 3 > income Statement > income Tax Expense
0
Annuals > 3 > income Statement > EBITDA
-
Annuals > 3 > income Statement > operating Margin
-
Annuals > 3 > income Statement > total Other Income Expense Net
-3551981
Annuals > 3 > income Statement > currency_symbol
USD
Annuals > 3 > balance Sheet > cash
10943437
Annuals > 3 > balance Sheet > short Term Investments
-
Annuals > 3 > balance Sheet > receivables
-
Annuals > 3 > balance Sheet > inventories
-
Annuals > 3 > balance Sheet > total Current Assets
11146953
Annuals > 3 > balance Sheet > property Plant Equipment
24837
Annuals > 3 > balance Sheet > total Assets
12891775
Annuals > 3 > balance Sheet > payables
1553154
Annuals > 3 > balance Sheet > short Term Debt
491039
Annuals > 3 > balance Sheet > long Term Debt
491039
Annuals > 3 > balance Sheet > total Liabilities
24258885
Annuals > 3 > balance Sheet > equity
-12265832
Annuals > 3 > balance Sheet > currency_symbol
USD
Annuals > 3 > cash Flow > net Income
-14387782
Annuals > 3 > cash Flow > depreciation
13836
Annuals > 3 > cash Flow > change In Working Capital
-
Annuals > 3 > cash Flow > cash From Operations
-9419762
Annuals > 3 > cash Flow > capital Expenditures
20096
Annuals > 3 > cash Flow > cash From Investing
-20096
Annuals > 3 > cash Flow > cash From Financing
13684855
Annuals > 3 > cash Flow > net Change In Cash
4265093
Annuals > 3 > cash Flow > currency_symbol
USD
Annuals > 3 > ratios > PE
-
Annuals > 3 > ratios > PB
-
Annuals > 3 > ratios > ROE
117.29968256535716
Annuals > 3 > ratios > ROA
-111.60435238747186
Annuals > 3 > ratios > FCF
-9439858
Annuals > 3 > ratios > Piotroski FScore
1
Annuals > 3 > ratios > fcf Percent
-
Annuals > 3 > health Score
41
Valuation > final Score
50
Valuation > verdict
Fair
Profitability > metrics > ROE
67.35825421525577
Profitability > metrics > ROA
-165.37597430301966
Profitability > final Score
55
Profitability > verdict
Weak
Risk > metrics > Interest Coverage
-10426.481308411216
Risk > final Score
-41676
Risk > verdict
High
Liquidity > metrics > Current Ratio
2.1743419331694085
Liquidity > metrics > Quick Ratio
2.1743419331694085
Liquidity > final Score
100
Liquidity > verdict
Great
Prev Valuations > 0
50
Prev Valuations > 1
50
Prev Valuations > 2
50
Prev Profitabilities > 0
55
Prev Profitabilities > 1
55
Prev Profitabilities > 2
55
Prev Risks > 0
-52939
Prev Risks > 1
-748
Prev Risks > 2
-365
Prev Liquidities > 0
87
Prev Liquidities > 1
100
Prev Liquidities > 2
15
Updated At
2026-01-20T21:24:40.399Z
Earnings History > 0 > period
2016-09-30
Earnings History > 0 > report Date
2016-11-14
Earnings History > 0 > date
2016-09-30
Earnings History > 0 > before After Market
-
Earnings History > 0 > currency
USD
Earnings History > 0 > eps Actual
-0.09
Earnings History > 0 > eps Estimate
-
Earnings History > 0 > eps Difference
0
Earnings History > 0 > surprise Percent
-
Earnings History > 1 > period
2016-06-30
Earnings History > 1 > report Date
2016-08-22
Earnings History > 1 > date
2016-06-30
Earnings History > 1 > before After Market
-
Earnings History > 1 > currency
USD
Earnings History > 1 > eps Actual
-0.05
Earnings History > 1 > eps Estimate
-
Earnings History > 1 > eps Difference
0
Earnings History > 1 > surprise Percent
-
Earnings History > 2 > period
2016-03-31
Earnings History > 2 > report Date
2016-05-16
Earnings History > 2 > date
2016-03-31
Earnings History > 2 > before After Market
-
Earnings History > 2 > currency
USD
Earnings History > 2 > eps Actual
-0.1
Earnings History > 2 > eps Estimate
-
Earnings History > 2 > eps Difference
0
Earnings History > 2 > surprise Percent
-
Earnings History > 3 > period
2015-12-31
Earnings History > 3 > report Date
2016-03-30
Earnings History > 3 > date
2015-12-31
Earnings History > 3 > before After Market
-
Earnings History > 3 > currency
USD
Earnings History > 3 > eps Actual
-0.2
Earnings History > 3 > eps Estimate
-
Earnings History > 3 > eps Difference
0
Earnings History > 3 > surprise Percent
-
Earnings History > 4 > period
2015-09-30
Earnings History > 4 > report Date
2015-11-16
Earnings History > 4 > date
2015-09-30
Earnings History > 4 > before After Market
-
Earnings History > 4 > currency
USD
Earnings History > 4 > eps Actual
-0.03
Earnings History > 4 > eps Estimate
-
Earnings History > 4 > eps Difference
0
Earnings History > 4 > surprise Percent
-
Earnings History > 5 > period
2015-06-30
Earnings History > 5 > report Date
2015-09-30
Earnings History > 5 > date
2015-06-30
Earnings History > 5 > before After Market
-
Earnings History > 5 > currency
USD
Earnings History > 5 > eps Actual
-0.0333
Earnings History > 5 > eps Estimate
-
Earnings History > 5 > eps Difference
0
Earnings History > 5 > surprise Percent
-
Earnings History > 6 > period
2015-03-31
Earnings History > 6 > report Date
2015-06-30
Earnings History > 6 > date
2015-03-31
Earnings History > 6 > before After Market
-
Earnings History > 6 > currency
USD
Earnings History > 6 > eps Actual
-0.1688
Earnings History > 6 > eps Estimate
-
Earnings History > 6 > eps Difference
0
Earnings History > 6 > surprise Percent
-
Earnings History > 7 > period
2014-12-31
Earnings History > 7 > report Date
2015-03-31
Earnings History > 7 > date
2014-12-31
Earnings History > 7 > before After Market
-
Earnings History > 7 > currency
USD
Earnings History > 7 > eps Actual
-0.166
Earnings History > 7 > eps Estimate
-
Earnings History > 7 > eps Difference
0
Earnings History > 7 > surprise Percent
-
Earnings History > 8 > period
2014-09-30
Earnings History > 8 > report Date
2014-12-31
Earnings History > 8 > date
2014-09-30
Earnings History > 8 > before After Market
-
Earnings History > 8 > currency
USD
Earnings History > 8 > eps Actual
0.18
Earnings History > 8 > eps Estimate
-
Earnings History > 8 > eps Difference
0
Earnings History > 8 > surprise Percent
-
Earnings History > 9 > period
2014-06-30
Earnings History > 9 > report Date
2014-09-30
Earnings History > 9 > date
2014-06-30
Earnings History > 9 > before After Market
-
Earnings History > 9 > currency
USD
Earnings History > 9 > eps Actual
0.0078
Earnings History > 9 > eps Estimate
-
Earnings History > 9 > eps Difference
0
Earnings History > 9 > surprise Percent
-
Earnings History > 10 > period
2014-03-31
Earnings History > 10 > report Date
2014-06-30
Earnings History > 10 > date
2014-03-31
Earnings History > 10 > before After Market
-
Earnings History > 10 > currency
USD
Earnings History > 10 > eps Actual
0.14
Earnings History > 10 > eps Estimate
-
Earnings History > 10 > eps Difference
0
Earnings History > 10 > surprise Percent
-
Earnings History > 11 > period
2013-12-31
Earnings History > 11 > report Date
2014-03-31
Earnings History > 11 > date
2013-12-31
Earnings History > 11 > before After Market
-
Earnings History > 11 > currency
USD
Earnings History > 11 > eps Actual
-0.0219
Earnings History > 11 > eps Estimate
-
Earnings History > 11 > eps Difference
0
Earnings History > 11 > surprise Percent
-
Earnings History > 12 > period
2013-09-30
Earnings History > 12 > report Date
2013-12-31
Earnings History > 12 > date
2013-09-30
Earnings History > 12 > before After Market
-
Earnings History > 12 > currency
USD
Earnings History > 12 > eps Actual
-1.5076
Earnings History > 12 > eps Estimate
-
Earnings History > 12 > eps Difference
0
Earnings History > 12 > surprise Percent
-
Earnings History > 13 > period
2013-06-30
Earnings History > 13 > report Date
2013-09-30
Earnings History > 13 > date
2013-06-30
Earnings History > 13 > before After Market
-
Earnings History > 13 > currency
USD
Earnings History > 13 > eps Actual
-0.75
Earnings History > 13 > eps Estimate
-
Earnings History > 13 > eps Difference
0
Earnings History > 13 > surprise Percent
-
Earnings History > 14 > period
2013-03-31
Earnings History > 14 > report Date
2013-06-30
Earnings History > 14 > date
2013-03-31
Earnings History > 14 > before After Market
-
Earnings History > 14 > currency
USD
Earnings History > 14 > eps Actual
-2.35
Earnings History > 14 > eps Estimate
-
Earnings History > 14 > eps Difference
0
Earnings History > 14 > surprise Percent
-
Earnings History > 15 > period
2012-12-31
Earnings History > 15 > report Date
2013-03-31
Earnings History > 15 > date
2012-12-31
Earnings History > 15 > before After Market
-
Earnings History > 15 > currency
USD
Earnings History > 15 > eps Actual
-0.2051
Earnings History > 15 > eps Estimate
-
Earnings History > 15 > eps Difference
0
Earnings History > 15 > surprise Percent
-
Earnings History > 16 > period
2012-09-30
Earnings History > 16 > report Date
2012-12-31
Earnings History > 16 > date
2012-09-30
Earnings History > 16 > before After Market
-
Earnings History > 16 > currency
USD
Earnings History > 16 > eps Actual
-1.8774
Earnings History > 16 > eps Estimate
-
Earnings History > 16 > eps Difference
0
Earnings History > 16 > surprise Percent
-
Earnings History > 17 > period
2012-06-30
Earnings History > 17 > report Date
2012-09-30
Earnings History > 17 > date
2012-06-30
Earnings History > 17 > before After Market
-
Earnings History > 17 > currency
USD
Earnings History > 17 > eps Actual
-0.6637
Earnings History > 17 > eps Estimate
-
Earnings History > 17 > eps Difference
0
Earnings History > 17 > surprise Percent
-
Earnings History > 18 > period
2012-03-31
Earnings History > 18 > report Date
2012-06-30
Earnings History > 18 > date
2012-03-31
Earnings History > 18 > before After Market
-
Earnings History > 18 > currency
USD
Earnings History > 18 > eps Actual
-0.0607
Earnings History > 18 > eps Estimate
-
Earnings History > 18 > eps Difference
0
Earnings History > 18 > surprise Percent
-
Earnings History > 19 > period
2011-12-31
Earnings History > 19 > report Date
2012-03-31
Earnings History > 19 > date
2011-12-31
Earnings History > 19 > before After Market
-
Earnings History > 19 > currency
USD
Earnings History > 19 > eps Actual
-0.566
Earnings History > 19 > eps Estimate
-
Earnings History > 19 > eps Difference
0
Earnings History > 19 > surprise Percent
-
Earnings History > 20 > period
2011-09-30
Earnings History > 20 > report Date
2011-12-31
Earnings History > 20 > date
2011-09-30
Earnings History > 20 > before After Market
-
Earnings History > 20 > currency
USD
Earnings History > 20 > eps Actual
-0.4627
Earnings History > 20 > eps Estimate
-
Earnings History > 20 > eps Difference
0
Earnings History > 20 > surprise Percent
-
Earnings History > 21 > period
2011-06-30
Earnings History > 21 > report Date
2011-09-30
Earnings History > 21 > date
2011-06-30
Earnings History > 21 > before After Market
-
Earnings History > 21 > currency
USD
Earnings History > 21 > eps Actual
-0.3879
Earnings History > 21 > eps Estimate
-
Earnings History > 21 > eps Difference
0
Earnings History > 21 > surprise Percent
-
Earnings History > 22 > period
2011-03-31
Earnings History > 22 > report Date
2011-06-30
Earnings History > 22 > date
2011-03-31
Earnings History > 22 > before After Market
-
Earnings History > 22 > currency
USD
Earnings History > 22 > eps Actual
-0.3938
Earnings History > 22 > eps Estimate
-
Earnings History > 22 > eps Difference
0
Earnings History > 22 > surprise Percent
-
Earnings History > 23 > period
2010-12-31
Earnings History > 23 > report Date
2011-03-31
Earnings History > 23 > date
2010-12-31
Earnings History > 23 > before After Market
-
Earnings History > 23 > currency
USD
Earnings History > 23 > eps Actual
-0.6435
Earnings History > 23 > eps Estimate
-
Earnings History > 23 > eps Difference
0
Earnings History > 23 > surprise Percent
-
Earnings History > 24 > period
2010-09-30
Earnings History > 24 > report Date
2010-12-31
Earnings History > 24 > date
2010-09-30
Earnings History > 24 > before After Market
-
Earnings History > 24 > currency
USD
Earnings History > 24 > eps Actual
-0.3466
Earnings History > 24 > eps Estimate
-
Earnings History > 24 > eps Difference
0
Earnings History > 24 > surprise Percent
-
Earnings History > 25 > period
2010-06-30
Earnings History > 25 > report Date
2010-06-30
Earnings History > 25 > date
2010-06-30
Earnings History > 25 > before After Market
-
Earnings History > 25 > currency
USD
Earnings History > 25 > eps Actual
-0.4779
Earnings History > 25 > eps Estimate
-
Earnings History > 25 > eps Difference
0
Earnings History > 25 > surprise Percent
-
Earnings History > 26 > period
2010-03-31
Earnings History > 26 > report Date
2010-03-31
Earnings History > 26 > date
2010-03-31
Earnings History > 26 > before After Market
-
Earnings History > 26 > currency
USD
Earnings History > 26 > eps Actual
-0.32
Earnings History > 26 > eps Estimate
-
Earnings History > 26 > eps Difference
0
Earnings History > 26 > surprise Percent
-
Earnings History > 27 > period
2008-12-31
Earnings History > 27 > report Date
2008-12-31
Earnings History > 27 > date
2008-12-31
Earnings History > 27 > before After Market
-
Earnings History > 27 > currency
USD
Earnings History > 27 > eps Actual
-1.6232
Earnings History > 27 > eps Estimate
-
Earnings History > 27 > eps Difference
0
Earnings History > 27 > surprise Percent
-
Earnings History > 28 > period
2008-09-30
Earnings History > 28 > report Date
2008-09-30
Earnings History > 28 > date
2008-09-30
Earnings History > 28 > before After Market
-
Earnings History > 28 > currency
USD
Earnings History > 28 > eps Actual
-0.8603
Earnings History > 28 > eps Estimate
-
Earnings History > 28 > eps Difference
0
Earnings History > 28 > surprise Percent
-
Earnings History > 29 > period
2008-06-30
Earnings History > 29 > report Date
2008-06-30
Earnings History > 29 > date
2008-06-30
Earnings History > 29 > before After Market
-
Earnings History > 29 > currency
USD
Earnings History > 29 > eps Actual
-2.2896
Earnings History > 29 > eps Estimate
-
Earnings History > 29 > eps Difference
0
Earnings History > 29 > surprise Percent
-
Arno Therapeutics, Inc., a biopharmaceutical company, develops products for the treatment of cancer and other life threatening diseases. The company's product development pipeline includes Onapristone, a type 1 anti-progestin hormone blocker that is in Phase I/II clinical study for the treatment of breast, endometrial, and others solid tumors in post-menopausal women; and advanced castration-resistant prostate cancer in men. Its product development pipeline also consists of AR-12, an orally available cancer treatment, which has completed Phase I clinical study for the treatment of solid tumors and hematological malignancies, as well as in Pre-clinical studies for the treatment of various anti-microbial targets. In addition, the company's product development pipeline comprises AR-42, a novel orally available cancer therapy that is in Phase I investigator-initiated clinical study for the treatment of hematological malignancies and solid tumors. The company has license agreements with Invivis Pharmaceuticals, Inc.; the Regents of the University of Minnesota; and the Ohio State University Innovation Foundation, as well as a co-development agreement with Leica Biosystems Newcastle Ltd. Arno Therapeutics, Inc. was founded in 2005 and is based in Flemington, New Jersey.
Stock Price
$0.00
decrease compared to yesterday.
Dividend
Frequency:
Rate:
N/ANext Payout:
N/ASri Lakshmi Saraswathi Textiles (Arni) Ltd Hits 52-Week Low Amidst Continued Downtrend Markets Mojo
Read more →Sunrest Lifescience Limited Tests 50 Day MA After Sharp Decline - Portfolio Risk Assessment & Rapid Portfolio Appreciation bollywoodhelpline.com
Read more →Showing 2 of 10
(Last Updated 2016-09-30)
Health Score
Return on Equity (ROE)
-
Very High
Low ≤ 5%
High ≥ 25%
Return on Assets (ROA)
-
Very Low
Low ≤ 2%
High ≥ 10%
* Institutions hold a combined 0.00% of the total shares of Arno Therapeutics
* Investors data is estimated based on stocks listed on Finnton that are currently held by Institution/Fund.
Date
—
EPS Estimate
—
Date
2016-09-30
EPS Actual
-0.09
EPS Estimate
—
EPS Difference
0
Surprise Percent
0%
(Last Updated 2016-09-30)
(Last Updated 2016-09-30)
Revenue
$ 0
Cost Of Revenue
$ 0
Gross Profit
$ 0
Operating Expenses
$ 0
Operating Income
$ 0
Interest Expense
$ 0
Pretax Income
$ 0
Net Income
$ 0
Income Tax Expense
$ 0
EBITDA
$ 0
Total Other Income Expense Net
$ 0
Earnings Per Share
0
Dividends Per Share
0
Shares Outstanding
0
Operating Margin
0%
(Last Updated 2016-09-30)
Cash
$ 0
Short Term Investments
$ 0
Receivables
$ 0
Inventories
$ 0
Total Current Assets
$ 0
Property Plant Equipment
$ 0
Total Assets
$ 0
Payables
$ 0
Short Term Debt
$ 0
Long Term Debt
$ 0
Total Liabilities
$ 0
Equity
$ 0
(Last Updated 2016-09-30)
Net Income
$ 0
Depreciation
$ 0
Change In Working Capital
$ 0
Cash From Operations
$ 0
Capital Expenditures
$ 0
Cash From Investing
$ 0
Cash From Financing
$ 0
Net Change In Cash
$ 0
Disclaimer: Finnton is a stock screener tool provided for informational and educational purposes only. The data, analysis, and insights offered on this website do not constitute financial, investment, tax, or legal advice. Users are solely responsible for their own investment decisions, and Finnton makes no guarantees regarding the accuracy, completeness, or reliability of the information provided. Past performance is not indicative of future results. Always conduct your own research and consult with a licensed financial advisor before making any investment decisions.